Chi Van Dang was named editor-in-chief of Cancer Research, a journal published by the American Association for Cancer Research.
Dang is the scientific director of the Ludwig Institute for Cancer Research, an international, not-for-profit organization of distinguished scientists dedicated to preventing and controlling cancer. He is also a professor in the molecular and cellular oncogenesis program at the Wistar Institute.
Dang’s lab was the first to report a link between an oncogene and altered cancer cell metabolism through the discovery that the oncogenic transcription factor MYC plays a pivotal role in the re-programming of fuel utilization in cancer cells, making cancers addicted to certain fuel sources. Research in the Dang laboratory currently focuses on exploiting metabolic vulnerabilities of cancer cells for therapeutic benefit.
Dang is the chair of the National Cancer Institute’s Board of Scientific Advisors, a member of the Blue-Ribbon Panel of former Vice President Joe Biden’s National Cancer Moonshot Initiative, a fellow of the American Academy of Arts and Sciences, and a member of the National Academy of Medicine.
